Harry Hollema

University Medical Center Groningen — Netherlands

Medicine · Health Sciences

71h-index17.0kcitations414works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Endometrial and Cervical Cancer Treatments(92), Ovarian cancer diagnosis and treatment(72), Cervical Cancer and HPV Research(71), Estrogen and related hormone effects(54), Genetic factors in colorectal cancer(50)

Publications414 total

High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in <i>BRCA1/2</i> germline pathogenic variant carriers
JNCI Journal of the National Cancer Institute·2024· 4 citedOpen Access
999 Significance of complete embedding of risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers
2024
1002 Incidence of peritoneal high-grade serous carcinoma after normal risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers
2024
Supplementary Figure S2 from Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer
2023Open Access
Supplementary Data from Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer
2023Open Access
Supplementary Table S1 from Germline &lt;i&gt;BRCA&lt;/i&gt;-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity
2023Open Access
Supplementary Figure S1 from Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer
2023Open Access
Supplementary Table S1 from Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer
2023Open Access
Supplementary Figures S1-S2 from Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer
2023Open Access
Data from Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
2023Open Access
Data from Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model
2023Open Access
Supplementary Table S2 from Germline &lt;i&gt;BRCA&lt;/i&gt;-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity
2023Open Access
Supplementary Table S2 from Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer
2023Open Access
Supplementary Materials from Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
2023Open Access
Supplementary Data from Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer
2023Open Access
Supplementary Fig. S3 from Germline &lt;i&gt;BRCA&lt;/i&gt;-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity
2023Open Access
Supplementary Fig. S5 from Germline &lt;i&gt;BRCA&lt;/i&gt;-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity
2023Open Access
Data from Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
2023Open Access
Data from Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer
2023Open Access
Supplementary Fig. S4 from Germline &lt;i&gt;BRCA&lt;/i&gt;-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity
2023Open Access
page 1 of 21Next →

Frequent Co-authors

Elisabeth G.E. de Vries(15), Hans W. Nijman(10), Ate G.J. van der Zee(9), Jan H. Kleibeuker(9), Robert M.W. Hofstra(9), Marian J.E. Mourits(8), Rolf H. Sijmons(7), Ate G.J. van der Zee(7), Charles H.C.M. Buys(6), Klaske A. ten Hoor(5), Toos Daemen(5), Wouter B. Nagengast(5), Maran J.W. Berends(5), Tineke van der Sluis(5), Geertruida H. de Bock(5), Johan R. de Jong(4), Marjolijn N. Lub–de Hooge(4), Ying Wu(4), Rob G.J. Mensink(4), Claudia Kempinga(4)